What's behind the push to make peptide therapies more readily available
•Peptide therapies are being marketed for their potential longevity and wellness benefits despite a lack of proven efficacy.
•These therapies are primarily sold through a grey market online, raising concerns about safety and regulation.
•Compounding pharmacies argue they should be permitted to legally produce these therapies to satisfy growing consumer demand.
المصدر: NPR | Source: NPRMarketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to meet demand.
(Image credit: George Frey/Bloomberg)
→Peptide therapies are being marketed for their potential longevity and wellness benefits despite a lack of proven efficacy.
→These therapies are primarily sold through a grey market online, raising concerns about safety and regulation.
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة NPR. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by NPR. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
